2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: Utility of susceptibility weighted imaging in the objective diagnosis of idiopathic Parkinson’s Disease: Is DaTscan necessary?

R. Ellis, M. Radon, M. Bonello, M. Steiger (Liverpool, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort

S.-M. Fereshtehnejad, J. Montplaisir, A. Pelletier, J.-F. Gagnon, D. Berg, R. Postuma (Montreal, QC, Canada)

Other · Exhibit Hall C

1:15pm-2:45pm: Vascular hemiballismus due to a lentiform nucleus infarct

D. Gams Massi, J. Nyassinde, K. Toure, N.S. Diagne, M. Ndiaye, A.G. Diop, M.M. Ndiaye (Dakar, Senegal)

Other · Exhibit Hall C

1:15pm-2:45pm: Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis

C. Tarolli, K. Andrzejewski, M. Bull, S. Goldenthal, M. O'Brien, T. Simuni, G. Zimmerman, K. Biglan, E.R. Dorsey (Rochester, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Vitamin D and Clinical Phenotypes of Parkinson’s Disease

F. Jamal, G. Jackson, S. Moore, A. Sarwar (Houston, TX, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Voice Therapy Normalizes Feedforward and Feedback Networks of the Speech Motor System

S. Narayana, C. Franklin, E. Peterson, D. Robin, P. Fox, L. Ramig (Memphis, TN, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Volume analysis and localization of midbrain hyperechogenecities via TCS and MRI

A. Plate, S.-A. Ahmadi, K. Boetzel (Munich, Germany)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Wearing Off Frequency in Different Hoehn-Yahr Stages in Parkinson’s Disease

H. Cotur Levent, E. Bayram, M. Akbostanci (Ankara, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia?

C. Colosimo, V. Misra, D. Charles, T.M. Chung, S. Om, P. Maisonobe (Terni, Italy)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: White Matter Microstructural Features of Motor Subtypes in De Novo, Drug Naïve Parkinson’s Disease Patient

M.-C. Wen, H. Heng, Z. Lu, Z. Xu, L.L. Chan, E.K. Tan, L. Tan (Singapore, Singapore)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C